HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy.

Abstract
Optic atrophy type 1 (OPA1, MIM 165500) is a dominantly inherited optic neuropathy occurring in 1 in 50,000 individuals that features progressive loss in visual acuity leading, in many cases, to legal blindness. Phenotypic variations and loss of retinal ganglion cells, as found in Leber hereditary optic neuropathy (LHON), have suggested possible mitochondrial impairment. The OPA1 gene has been localized to 3q28-q29 (refs 13-19). We describe here a nuclear gene, OPA1, that maps within the candidate region and encodes a dynamin-related protein localized to mitochondria. We found four different OPA1 mutations, including frameshift and missense mutations, to segregate with the disease, demonstrating a role for mitochondria in retinal ganglion cell pathophysiology.
AuthorsC Delettre, G Lenaers, J M Griffoin, N Gigarel, C Lorenzo, P Belenguer, L Pelloquin, J Grosgeorge, C Turc-Carel, E Perret, C Astarie-Dequeker, L Lasquellec, B Arnaud, B Ducommun, J Kaplan, C P Hamel
JournalNature genetics (Nat Genet) Vol. 26 Issue 2 Pg. 207-10 (Oct 2000) ISSN: 1061-4036 [Print] United States
PMID11017079 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • GTP Phosphohydrolases
  • OPA1 protein, human
  • Dynamins
Topics
  • Amino Acid Sequence
  • Cell Nucleus (genetics)
  • Chromosome Mapping
  • Chromosomes, Human, Pair 3
  • Dynamins
  • Exons
  • Female
  • GTP Phosphohydrolases (chemistry, genetics)
  • Genes, Dominant
  • Humans
  • In Situ Hybridization, Fluorescence
  • Male
  • Mitochondria (genetics)
  • Molecular Sequence Data
  • Mutation
  • Optic Atrophy (genetics)
  • Pedigree
  • Polymorphism, Genetic
  • Saccharomyces cerevisiae (genetics)
  • Schizosaccharomyces (genetics)
  • Sequence Alignment
  • Sequence Homology, Amino Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: